Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Inhibikase Therapeutics, Inc. (IKT)

1.5500 -0.1200 (-7.19%)
At close: October 30 at 4:00:00 PM EDT
1.5500 0.0000 (0.00%)
After hours: October 30 at 4:00:16 PM EDT
Trade IKT on Coinbase

Earnings Trends

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue --
Earnings -19.59M
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q2

FY26

Q3

FY26

-15M
-10M
-5M
0
0.0%

Revenue Estimate

Currency in USD
Current Qtr. (Dec 2026)
Next Qtr. (Mar 2027)
Current Year (2026)
Next Year (2027)
No. of Analysts
8 4 8 8
Avg. Estimate
187.5k -- 187.5k 250k
Low Estimate
-- -- -- --
High Estimate
1.5M -- 1.5M 2M
Year Ago Sales
-- -- -- 187.5k
Sales Growth (year/est)
0.00% -- 0.00% 33.33%

Earnings Estimate

GAAP
Normalized
Currency in USD
Current Qtr. (Dec 2026)
Next Qtr. (Mar 2027)
Current Year (2026)
Next Year (2027)
No. of Analysts
4 3 5 5
Avg. Estimate
-0.13 -0.11 -0.4 -0.42
Low Estimate
-0.16 -0.13 -0.45 -0.48
High Estimate
-0.11 -0.09 -0.33 -0.37
Year Ago EPS
-- -- -- -0.4

Earnings History

GAAP
Normalized
Currency in USD
3/31/2026
6/30/2026
9/30/2026
EPS Est.
-0.09 -0.09 -0.12
EPS Actual
-- -0.11 -0.11
Difference
-- -0.02 0.02
Surprise %
-- -17.86% 12.00%

EPS Trend

GAAP
Normalized
Currency in USD
Current Qtr. (Dec 2026)
Next Qtr. (Mar 2027)
Current Year (2026)
Next Year (2027)
Current Estimate
-0.13 -0.11 -0.4 -0.42
7 Days Ago
-0.12 -0.12 -0.44 -0.43
30 Days Ago
-0.12 -0.12 -0.44 -0.43
60 Days Ago
-0.1 -0.12 -0.44 -0.42
90 Days Ago
-0.09 0 -0.37 -0.38

EPS Revisions

GAAP
Normalized
Currency in USD
Current Qtr. (Dec 2026)
Next Qtr. (Mar 2027)
Current Year (2026)
Next Year (2027)
Up Last 7 Days
-- -- -- --
Up Last 30 Days
-- -- -- --
Down Last 7 Days
1 -- 1 1
Down Last 30 Days
1 -- 1 1

Growth Estimates

Symbol Current Qtr. Next Qtr. Current Year Next Year
IKT
-- -- -- -5.00%
S&P 500
26.99% 26.80% 32.87% 16.85%

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: